Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
2R37CA030558-07
Application #
3482196
Study Section
Experimental Immunology Study Section (EI)
Project Start
1981-07-01
Project End
1992-06-30
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
7
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Gaiger, A; Carter, L; Greinix, H et al. (2001) WT1-specific serum antibodies in patients with leukemia. Clin Cancer Res 7:761s-765s
Bernhard, H; Huseby, E S; Hand, S L et al. (2000) Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression. Immunobiology 201:568-82
Cignetti, A; Bryant, E; Allione, B et al. (1999) CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells. Blood 94:2048-55
Clark, J G; Madtes, D K; Hackman, R C et al. (1998) Lung injury induced by alloreactive Th1 cells is characterized by host-derived mononuclear cell inflammation and activation of alveolar macrophages. J Immunol 161:1913-20
Chen, W; Chatta, G S; Rubin, W D et al. (1998) T cells specific for a polymorphic segment of CD45 induce graft-versus-host disease with predominant pulmonary vasculitis. J Immunol 161:909-18
Disis, M L; Cheever, M A (1997) HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer. Adv Cancer Res 71:343-71
Disis, M L; Pupa, S M; Gralow, J R et al. (1997) High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer. J Clin Oncol 15:3363-7
Cheever, M A; Chen, W (1997) Therapy with cultured T cells: principles revisited. Immunol Rev 157:177-94
Liu, K J; Chatta, G S; Twardzik, D R et al. (1997) Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapy. J Immunol 159:472-80
Disis, M L; Bernhard, H; Shiota, F M et al. (1996) Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. Blood 88:202-10

Showing the most recent 10 out of 44 publications